Analyst Valuation and EPS Growth for CVS Health (NYSE:CVS)

Earnings results for CVS Health (NYSE:CVS)

CVS Health Corporation is expected* to report earnings on 05/04/2021 before market open. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 10 analysts’ forecasts, the consensus EPS forecast for the quarter is $1.72. The reported EPS for the same quarter last year was $1.9100000000000001.

CVS Health last announced its quarterly earnings results on February 15th, 2021. The pharmacy operator reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. The company had revenue of $69.55 billion for the quarter, compared to the consensus estimate of $68.67 billion. CVS Health has generated $7.08 earnings per share over the last year and currently has a price-to-earnings ratio of 12.6. CVS Health has confirmed that its next quarterly earnings report will be published on Tuesday, May 4th, 2021. CVS Health will be holding an earnings conference call on Tuesday, May 4th. Interested parties can register for or listen to the call using this link.

Analyst Opinion on CVS Health (NYSE:CVS)

15 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $84.31, predicting that the stock has a possible upside of 10.35%. The high price target for CVS is $101.00 and the low price target for CVS is $66.00. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of “Buy.”

CVS Health has received a consensus rating of Buy. The company’s average rating score is 2.73, and is based on 11 buy ratings, 4 hold ratings, and no sell ratings. According to analysts’ consensus price target of $84.31, CVS Health has a forecasted upside of 10.4% from its current price of $76.40. CVS Health has only been the subject of 3 research reports in the past 90 days.

Dividend Strength: CVS Health (NYSE:CVS)

CVS Health pays a meaningful dividend of 2.62%, higher than the bottom 25% of all stocks that pay dividends. CVS Health has only been increasing its dividend for 1 years. The dividend payout ratio of CVS Health is 28.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CVS Health will have a dividend payout ratio of 26.56% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

Insiders buying/selling: CVS Health (NYSE:CVS)

In the past three months, CVS Health insiders have sold 20,232.45% more of their company’s stock than they have bought. Specifically, they have bought $216,000.00 in company stock and sold $43,918,083.00 in company stock. Only 0.46% of the stock of CVS Health is held by insiders. 74.21% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of CVS Health (NYSE:CVS

Earnings for CVS Health are expected to grow by 1.35% in the coming year, from $7.43 to $7.53 per share. The P/E ratio of CVS Health is 12.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.05. The P/E ratio of CVS Health is 12.63, which means that it is trading at a less expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 36.54. CVS Health has a PEG Ratio of 1.72. PEG Ratios above 1 indicate that a company could be overvalued. CVS Health has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here